Drugs News and Research

RSS

Tactics used by drug reps to manipulate physicians revealed

In a unique collaborative paper in PLoS Medicine , Georgetown University Medical Center's Adriane Fugh-Berman and a former Eli Lilly drug rep reveal the tactics used by drug reps to manipulate physicians into selling drugs.

25 Apr 2007

Examination of execution by lethal injection

Execution by lethal injection may cause death by asphyxiation, and prisoners being executed may be conscious and may experience pain, claim the authors of a new study published this week in PLoS Medicine.

25 Apr 2007

Did drug reps encourage doctors to prescribe gabapentin for nonapproved uses?

A new study published in PLoS Medicine suggests that so-called "detail" visits to doctors made by drug company representatives can involve promotion of drugs for non-approved, "off-label" uses.

25 Apr 2007

Chronically ill prisoners can face great healthcare problems, but others inmates enjoy improved health

People with chronic illnesses can experience great difficulties in prison, but people such as drug addicts and the homeless may find their healthcare improves, according to a study in the latest Journal of Advanced Nursing.

25 Apr 2007

FDA panel recommends new HIV drug Maraviroc

Approval is expected to be granted in the United States for a new drug to treat HIV infections.

24 Apr 2007

Execution by lethal injection slow, cruel and a violation of the constitution

The authors of a new study are suggesting that executions carried out by lethal injections possibly cause death by asphyxiation, and the prisoners being executed may be conscious and may experience pain.

24 Apr 2007

Resistance to anti-HIV drugs in Uganda developed due to drug supply problems

Some HIV-infected patients in Uganda who self-paid for their antiretroviral medications experienced interruptions in drug supply due to either financial demands or supply logistical disruptions.

24 Apr 2007

New FDA audio broadcasts provide emerging drug safety information

The U.S. Food and Drug Administration (FDA) is alerting health care professionals and consumers to the availability of audio broadcasts that provide emerging drug safety information.

24 Apr 2007

Road accidents are the biggest killer of young people

Young people from more than 100 countries gathered at the United Nations in Geneva, Switzerland, for the first ever World Youth Assembly for Road Safety and to mark the first UN Global Road Safety Week.

24 Apr 2007

Pharmacyclics announces NDA for Xcytrin injection

Pharmacyclics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has filed the company's New Drug Application (NDA) for Xcytrin (motexafin gadolinium) Injection.

24 Apr 2007

New understanding of schizophrenia

New research helps bridge an important gap in understanding schizophrenia, providing the best evidence to date that defects in the brain's white matter are a key contributor to the disease, which affects about 1 percent of people worldwide.

24 Apr 2007

NanoFrontiers: Visions for the Future of Nanotechnology

Controlling the properties and behavior of matter at the smallest scale, in effect, "domesticating atoms",can help to overcome some of the world's biggest challenges, concludes a new report on how diverse experts view the future of nanotechnology.

24 Apr 2007

New methods for treating lung cancer cells that have become resistant to new anti-cancer agents

Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center have developed methods for treating lung cancer cells that have become resistant to new anti-cancer agents.

24 Apr 2007

FDA approves generic versions of Ambien

The U.S. Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

24 Apr 2007

Key to understanding all biological processes is recognition

A human body has more than 10 to the power of 27 molecules with about one hundred thousand different shapes and functions.

24 Apr 2007

Potential therapeutic target for multiple sclerosis

Oregon Health & Science University neuroscientists are eyeing a protein as a potential therapeutic target for multiple sclerosis because de-activating it protects nerve fibers from damage.

24 Apr 2007

Are higher doses and higher costs for cholesterol drugs worth the extra money?

When it comes to cholesterol-lowering drugs, more is better. At least, that's what heart doctors and heart patients have been hearing in recent years.

24 Apr 2007

Abbott continues drug blacklist in Thailand, says AIDS Healthcare Foundation

AIDS Healthcare Foundation has chastised Abbott Laboratories for its 'quid pro quo' offer to the Government of Thailand to lower its price for Abbott's key AIDS drug, Aluvia (a heat-stable tablet version of Kaletra) to approximately USD$800 per patient per year -- an offer contingent upon Abbott's demand that Thailand immediately halt issuing compulsory licenses for the generic manufacture of this lifesaving drug.

24 Apr 2007

Klotho proteins important players in future therapies for diabetes, obesity and kidney disease

A relative of the anti-aging gene Klotho helps activate a hormone that can lower blood glucose levels in fat cells of mice, making it a novel target for developing drugs to treat human obesity and diabetes, UT Southwestern Medical Center researchers have found.

24 Apr 2007